Comparison of the functional blockade of rat substance P (NK₁) receptors by GR205171, RP67580, SR140333 and NKP-608RUPNIAK, Nadia M. J; CARLSON, Emma J; CASCIERI, Margaret A et al.Neuropharmacology. 2003, Vol 45, Num 2, pp 231-241, issn 0028-3908, 11 p.Article

Ethanol inhibits the binding of substance P to rat brain cortex NK₁ receptorsSCARRONE, S; CAPPELLI, A; CUPELLO, A et al.Neurochemical research. 2003, Vol 28, Num 8, pp 1159-1162, issn 0364-3190, 4 p.Article

Pharmacological properties of peptides derived from an antibody against the tachykinin NK₁ receptor for the neuropeptide substance PWIJKHUISEN, Anne; TYMCIU, Sylvie; FISCHER, Jacqueline et al.European journal of pharmacology. 2003, Vol 468, Num 3, pp 175-182, issn 0014-2999, 8 p.Article

Cyclosporin A is a substance P (tachykinin NK₁) receptor antagonistGITTER, B. D; WATERS, D. C; THRELKELD, P. G et al.European journal of pharmacology. Molecular pharmacology section. 1995, Vol 289, Num 3, pp 439-446, issn 0922-4106Article

Tonic Postganglionic Sympathetic Inhibition Induced by Afferent Renal Nerves?DITTING, Tilmann; FREISINGER, Wolfgang; SIEGEL, Kirsten et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 59, Num 2, pp 467-476, issn 0194-911X, 10 p., 2Article

NK₁ and NK₂ receptors are similar in man and rabbitCOGE, F; REGOLI, D.Neuropeptides (Edinburgh). 1994, Vol 26, Num 6, pp 385-390, issn 0143-4179Article

SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1 tachykinin receptor : characterization on the U373MG cell lineOURY-DONAT, F; LEFEVRE, I. A; THURNEYSSEN, O et al.Journal of neurochemistry. 1994, Vol 62, Num 4, pp 1399-1407, issn 0022-3042Article

Characterization of a human NK₁ tachykinin receptor in the astrocytoma cell line U 373 MGHEUILLET, E; MENAGER, J; FARDIN, V et al.Journal of neurochemistry. 1993, Vol 60, Num 3, pp 868-876, issn 0022-3042Article

Synthesis and biological activity of NK₁ tachykinin antagonists not containing D-residuesPOULOS, C; ANTONIOU, M; PATACCHINI, R et al.Neuropeptides (Edinburgh). 1994, Vol 26, Num 1, pp 55-57, issn 0143-4179Article

Substance P-evoked calcium mobilization and ionic current activation in the human astrocytoma cell line U 373 MG : pharmacological characterizationPRADIER, L; HEUILLET, E; HUBERT, J. P et al.Journal of neurochemistry. 1993, Vol 61, Num 5, pp 1850-1858, issn 0022-3042Article

FR 113680 : a novel tripeptide substance P antagonist with NK₁ receptor selectivityMORIMOTO, H; MURAI, M; MAEDA, Y et al.British journal of pharmacology. 1992, Vol 106, Num 1, pp 123-126, issn 0007-1188Article

Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonistTOUSIGNANT, C; CHRETIEN, L; GUILLEMETTE, G et al.Brain research. 1992, Vol 596, Num 1-2, pp 243-250, issn 0006-8993Article

Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptorELLING, C. E; MØLLER NIELSEN, S; SCHWARTZ, T. W et al.Nature (London). 1995, Vol 374, Num 6517, pp 74-77, issn 0028-0836Article

Quinuclidine based NK-1 antagonists. II: Determination of the absolute stereochemical requirementsSWAIN, C. J; SEWARD, E. M; SABIN, V et al.Bioorganic & medicinal chemistry letters (Print). 1993, Vol 3, Num 8, pp 1703-1706, issn 0960-894XArticle

A water-soluble, stable dipeptide NK₁ receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects : S18523BONNET, J; KUCHARCZYK, N; ROBINEAU, P et al.European journal of pharmacology. 1996, Vol 310, Num 1, pp 37-46, issn 0014-2999Article

Investigation of the specificity of FK 888 as a tachykinin NK₁ receptor antagonistZUN-YI WANG; TUNG, S. R; STRICHARTZ, G. R et al.British journal of pharmacology. 1994, Vol 111, Num 4, pp 1342-1346, issn 0007-1188Article

Comparison of tachykinin NK₁ receptors in human IM9 and U373 MG cells, using antagonist (FK888, (±)-CP-96,345, and RP 67580) bindingGOSO, C; POTIER, E; MANZINI, S et al.European journal of pharmacology. 1994, Vol 254, Num 3, pp 221-227, issn 0014-2999Article

The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell linesMUNOZ, M; ROSSO, M; PEREZ, A et al.Neuropeptides (Edinburgh). 2005, Vol 39, Num 4, pp 427-432, issn 0143-4179, 6 p.Article

Synergistic antiemetic interactions between serotonergic 5-HT₃ and tachykininergic NK₁-receptor antagonists in the least shrew (Cryptotis parva)DARMANI, Nissar A; CHEBOLU, Seetha; AMOS, Barry et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 4, pp 573-579, issn 0091-3057, 7 p.Article

Enantioselective inhibition of the formalin paw late phase by the NK₁ receptor antagonist L-733,060 in gerbilsRUPNIAK, N. M. J; CARLSON, E; BOYCE, S et al.Pain (Amsterdam). 1996, Vol 67, Num 1, pp 189-195, issn 0304-3959Article

In situ hybridization analysis of substance P receptor in the rat retinaKONDOH, A; HOUTANI, T; UEYAMA, T et al.Experimental brain research. 1996, Vol 112, Num 2, pp 181-186, issn 0014-4819Article

Production et caractérisation d'anticorps dirigés contre le récepteur de la substance P par l'approche des peptides complémentaires = Production and characterization of antibodies directed against the substance P receptor using the complementary peptide methodologyDery, Olivier; Couraud, J.-Y.1996, 236 p.Thesis

Comparative behavioural profile of centrally administered tachykinin NK₁, NK₂ and NK₃ receptor agonists in the guinea-pigPIOT, O; BETSCHART, J; GRALL, I et al.British journal of pharmacology. 1995, Vol 116, Num 5, pp 2496-2502, issn 0007-1188Article

Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouseUKAI, M; SHINKAI, N; OHASHI, K et al.Brain research. 1995, Vol 673, Num 2, pp 335-338, issn 0006-8993Article

Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptorHUANG, R.-R. C; HONG YU; STRADER, C. D et al.Biochemistry (Easton). 1994, Vol 33, Num 10, pp 3007-3013, issn 0006-2960Article